Table 2.
Adjusted incidence rate-ratios for sudden cardiac death according to antipsychotic current use status* and frequently prescribed individual drugs.
Person-years | Sudden Deaths | IRR | 95% CI | p-value | |
---|---|---|---|---|---|
Nonuser | 624,591 | 895 | 1 | Reference | |
Former user | 189,981 | 311 | 1.13 | 0.98–1.30 | .0822 |
Current, typical** | 86,735 | 255 | 2.00 | 1.69–2.35 | <.0001 |
Haloperidol | 21,728 | 58 | 1.61 | 1.16–2.24 | 0.0049 |
Thioridazine | 15,715 | 65 | 3.19 | 2.41–4.21 | <.0001 |
Current, atypical** | 79,589 | 223 | 2.27 | 1.89–2.73 | <.0001 |
Clozapine | 4,654 | 19 | 3.67 | 1.94–6.94 | <.0001 |
Olanzapine | 27,257 | 75 | 2.04 | 1.52–2.74 | <.0001 |
Quetiapine | 17,355 | 40 | 1.88 | 1.30–2.71 | 0.0008 |
Risperidone | 24,589 | 85 | 2.91 | 2.26–3.76 | <.0001 |
Excludes 45,381 person-years and134 deaths for indeterminate users of antipsychotics as well as15,883 person-years and 52 deaths for concurrent users of multiple antipsychotics.
Adjusted for dose, see Appendix 1.